aluates Reports

$ 0.0

Automative

Global Solid Tumor Therapeutics Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-9K14053

Global Solid Tumor Therapeutics Market Research Report 2023

BUY CHAPTERS

Global Solid Tumor Therapeutics Market Research Report 2025

Code: QYRE-Auto-9K14053

Report

September 2025

Pages:82

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Hoffmann La Roche

Johnson & Johnson

Novartis

Astrazeneca plc

Biogen Idec

Boehringer Ingelheim

GlaxoSmithKline PLC

Eli Lilly

Kyowa Hakko Kirin

Abbott Laboratories

Baxter International

Johnson & Johnson

Solid Tumor Therapeutics Market Size

The global market for Solid Tumor Therapeutics was valued at US$ 142170 million in the year 2024 and is projected to reach a revised size of US$ 249700 million by 2031, growing at a CAGR of 8.5% during the forecast period.

Solid Tumor Therapeutics Market

In cancer, solid tumors are formed by aggregation of abnormal tissues that do not comprise of any liquid or cyst.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Solid Tumor Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Solid Tumor Therapeutics.

The Solid Tumor Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Solid Tumor Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Solid Tumor Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Solid Tumor Therapeutics Market Report

Report Metric	Details
Report Name	Solid Tumor Therapeutics Market
Accounted market size in year	US$ 142170 million
Forecasted market size in 2031	US$ 249700 million
CAGR	8.5%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Chemotherapy Hormone Therapy Immunotherapy Targeted Therapy
Segment by Application	Breast Cancer Lung Cancer Colorectal Cancer Prostate Cancer Cervical Cancer Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Hoffmann-La Roche, Johnson & Johnson, Novartis, AstraZeneca, Biogen Idec, Boehringer Ingelheim, GlaxoSmithKline, Eli Lilly, Kyowa Hakko Kirin, Abbott Laboratories, Baxter International
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Solid Tumor Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Solid Tumor Therapeutics Market growing?

Ans: The Solid Tumor Therapeutics Market witnessing a CAGR of 8.5% during the forecast period 2025-2031.

What is the Solid Tumor Therapeutics Market size in 2031?

Ans: The Solid Tumor Therapeutics Market size in 2031 will be US$ 249700 million.

Who are the main players in the Solid Tumor Therapeutics Market report?

Ans: The main players in the Solid Tumor Therapeutics Market are Hoffmann-La Roche, Johnson & Johnson, Novartis, AstraZeneca, Biogen Idec, Boehringer Ingelheim, GlaxoSmithKline, Eli Lilly, Kyowa Hakko Kirin, Abbott Laboratories, Baxter International

What are the Application segmentation covered in the Solid Tumor Therapeutics Market report?

Ans: The Applications covered in the Solid Tumor Therapeutics Market report are Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Cervical Cancer, Others

What are the Type segmentation covered in the Solid Tumor Therapeutics Market report?

Ans: The Types covered in the Solid Tumor Therapeutics Market report are Chemotherapy, Hormone Therapy, Immunotherapy, Targeted Therapy

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Solid Tumor Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Chemotherapy

1.2.3 Hormone Therapy

1.2.4 Immunotherapy

1.2.5 Targeted Therapy

1.3 Market by Application

1.3.1 Global Solid Tumor Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Breast Cancer

1.3.3 Lung Cancer

1.3.4 Colorectal Cancer

1.3.5 Prostate Cancer

1.3.6 Cervical Cancer

1.3.7 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Solid Tumor Therapeutics Market Perspective (2020-2031)

2.2 Global Solid Tumor Therapeutics Growth Trends by Region

2.2.1 Global Solid Tumor Therapeutics Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Solid Tumor Therapeutics Historic Market Size by Region (2020-2025)

2.2.3 Solid Tumor Therapeutics Forecasted Market Size by Region (2026-2031)

2.3 Solid Tumor Therapeutics Market Dynamics

2.3.1 Solid Tumor Therapeutics Industry Trends

2.3.2 Solid Tumor Therapeutics Market Drivers

2.3.3 Solid Tumor Therapeutics Market Challenges

2.3.4 Solid Tumor Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Solid Tumor Therapeutics Players by Revenue

3.1.1 Global Top Solid Tumor Therapeutics Players by Revenue (2020-2025)

3.1.2 Global Solid Tumor Therapeutics Revenue Market Share by Players (2020-2025)

3.2 Global Solid Tumor Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Solid Tumor Therapeutics Revenue

3.4 Global Solid Tumor Therapeutics Market Concentration Ratio

3.4.1 Global Solid Tumor Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Solid Tumor Therapeutics Revenue in 2024

3.5 Global Key Players of Solid Tumor Therapeutics Head office and Area Served

3.6 Global Key Players of Solid Tumor Therapeutics, Product and Application

3.7 Global Key Players of Solid Tumor Therapeutics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Solid Tumor Therapeutics Breakdown Data by Type

4.1 Global Solid Tumor Therapeutics Historic Market Size by Type (2020-2025)

4.2 Global Solid Tumor Therapeutics Forecasted Market Size by Type (2026-2031)

5 Solid Tumor Therapeutics Breakdown Data by Application

5.1 Global Solid Tumor Therapeutics Historic Market Size by Application (2020-2025)

5.2 Global Solid Tumor Therapeutics Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Solid Tumor Therapeutics Market Size (2020-2031)

6.2 North America Solid Tumor Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Solid Tumor Therapeutics Market Size by Country (2020-2025)

6.4 North America Solid Tumor Therapeutics Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Solid Tumor Therapeutics Market Size (2020-2031)

7.2 Europe Solid Tumor Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Solid Tumor Therapeutics Market Size by Country (2020-2025)

7.4 Europe Solid Tumor Therapeutics Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Solid Tumor Therapeutics Market Size (2020-2031)

8.2 Asia-Pacific Solid Tumor Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Solid Tumor Therapeutics Market Size by Region (2020-2025)

8.4 Asia-Pacific Solid Tumor Therapeutics Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Solid Tumor Therapeutics Market Size (2020-2031)

9.2 Latin America Solid Tumor Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Solid Tumor Therapeutics Market Size by Country (2020-2025)

9.4 Latin America Solid Tumor Therapeutics Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Solid Tumor Therapeutics Market Size (2020-2031)

10.2 Middle East & Africa Solid Tumor Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Solid Tumor Therapeutics Market Size by Country (2020-2025)

10.4 Middle East & Africa Solid Tumor Therapeutics Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Hoffmann-La Roche

11.1.1 Hoffmann-La Roche Company Details

11.1.2 Hoffmann-La Roche Business Overview

11.1.3 Hoffmann-La Roche Solid Tumor Therapeutics Introduction

11.1.4 Hoffmann-La Roche Revenue in Solid Tumor Therapeutics Business (2020-2025)

11.1.5 Hoffmann-La Roche Recent Development

11.2 Johnson & Johnson

11.2.1 Johnson & Johnson Company Details

11.2.2 Johnson & Johnson Business Overview

11.2.3 Johnson & Johnson Solid Tumor Therapeutics Introduction

11.2.4 Johnson & Johnson Revenue in Solid Tumor Therapeutics Business (2020-2025)

11.2.5 Johnson & Johnson Recent Development

11.3 Novartis

11.3.1 Novartis Company Details

11.3.2 Novartis Business Overview

11.3.3 Novartis Solid Tumor Therapeutics Introduction

11.3.4 Novartis Revenue in Solid Tumor Therapeutics Business (2020-2025)

11.3.5 Novartis Recent Development

11.4 AstraZeneca

11.4.1 AstraZeneca Company Details

11.4.2 AstraZeneca Business Overview

11.4.3 AstraZeneca Solid Tumor Therapeutics Introduction

11.4.4 AstraZeneca Revenue in Solid Tumor Therapeutics Business (2020-2025)

11.4.5 AstraZeneca Recent Development

11.5 Biogen Idec

11.5.1 Biogen Idec Company Details

11.5.2 Biogen Idec Business Overview

11.5.3 Biogen Idec Solid Tumor Therapeutics Introduction

11.5.4 Biogen Idec Revenue in Solid Tumor Therapeutics Business (2020-2025)

11.5.5 Biogen Idec Recent Development

11.6 Boehringer Ingelheim

11.6.1 Boehringer Ingelheim Company Details

11.6.2 Boehringer Ingelheim Business Overview

11.6.3 Boehringer Ingelheim Solid Tumor Therapeutics Introduction

11.6.4 Boehringer Ingelheim Revenue in Solid Tumor Therapeutics Business (2020-2025)

11.6.5 Boehringer Ingelheim Recent Development

11.7 GlaxoSmithKline

11.7.1 GlaxoSmithKline Company Details

11.7.2 GlaxoSmithKline Business Overview

11.7.3 GlaxoSmithKline Solid Tumor Therapeutics Introduction

11.7.4 GlaxoSmithKline Revenue in Solid Tumor Therapeutics Business (2020-2025)

11.7.5 GlaxoSmithKline Recent Development

11.8 Eli Lilly

11.8.1 Eli Lilly Company Details

11.8.2 Eli Lilly Business Overview

11.8.3 Eli Lilly Solid Tumor Therapeutics Introduction

11.8.4 Eli Lilly Revenue in Solid Tumor Therapeutics Business (2020-2025)

11.8.5 Eli Lilly Recent Development

11.9 Kyowa Hakko Kirin

11.9.1 Kyowa Hakko Kirin Company Details

11.9.2 Kyowa Hakko Kirin Business Overview

11.9.3 Kyowa Hakko Kirin Solid Tumor Therapeutics Introduction

11.9.4 Kyowa Hakko Kirin Revenue in Solid Tumor Therapeutics Business (2020-2025)

11.9.5 Kyowa Hakko Kirin Recent Development

11.10 Abbott Laboratories

11.10.1 Abbott Laboratories Company Details

11.10.2 Abbott Laboratories Business Overview

11.10.3 Abbott Laboratories Solid Tumor Therapeutics Introduction

11.10.4 Abbott Laboratories Revenue in Solid Tumor Therapeutics Business (2020-2025)

11.10.5 Abbott Laboratories Recent Development

11.11 Baxter International

11.11.1 Baxter International Company Details

11.11.2 Baxter International Business Overview

11.11.3 Baxter International Solid Tumor Therapeutics Introduction

11.11.4 Baxter International Revenue in Solid Tumor Therapeutics Business (2020-2025)

11.11.5 Baxter International Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Hoffmann La Roche

Johnson & Johnson

Novartis

Astrazeneca plc

Biogen Idec

Boehringer Ingelheim

GlaxoSmithKline PLC

Eli Lilly

Kyowa Hakko Kirin

Abbott Laboratories

Baxter International

Johnson & Johnson

List of Tables

Table 1. Global Solid Tumor Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Chemotherapy

Table 3. Key Players of Hormone Therapy

Table 4. Key Players of Immunotherapy

Table 5. Key Players of Targeted Therapy

Table 6. Global Solid Tumor Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Solid Tumor Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Solid Tumor Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global Solid Tumor Therapeutics Market Share by Region (2020-2025)

Table 10. Global Solid Tumor Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global Solid Tumor Therapeutics Market Share by Region (2026-2031)

Table 12. Solid Tumor Therapeutics Market Trends

Table 13. Solid Tumor Therapeutics Market Drivers

Table 14. Solid Tumor Therapeutics Market Challenges

Table 15. Solid Tumor Therapeutics Market Restraints

Table 16. Global Solid Tumor Therapeutics Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global Solid Tumor Therapeutics Market Share by Players (2020-2025)

Table 18. Global Top Solid Tumor Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Solid Tumor Therapeutics as of 2024)

Table 19. Ranking of Global Top Solid Tumor Therapeutics Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by Solid Tumor Therapeutics Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of Solid Tumor Therapeutics, Headquarters and Area Served

Table 22. Global Key Players of Solid Tumor Therapeutics, Product and Application

Table 23. Global Key Players of Solid Tumor Therapeutics, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Solid Tumor Therapeutics Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global Solid Tumor Therapeutics Revenue Market Share by Type (2020-2025)

Table 27. Global Solid Tumor Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global Solid Tumor Therapeutics Revenue Market Share by Type (2026-2031)

Table 29. Global Solid Tumor Therapeutics Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global Solid Tumor Therapeutics Revenue Market Share by Application (2020-2025)

Table 31. Global Solid Tumor Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global Solid Tumor Therapeutics Revenue Market Share by Application (2026-2031)

Table 33. North America Solid Tumor Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America Solid Tumor Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America Solid Tumor Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe Solid Tumor Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe Solid Tumor Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe Solid Tumor Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific Solid Tumor Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific Solid Tumor Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific Solid Tumor Therapeutics Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America Solid Tumor Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America Solid Tumor Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America Solid Tumor Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa Solid Tumor Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa Solid Tumor Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa Solid Tumor Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 48. Hoffmann-La Roche Company Details

Table 49. Hoffmann-La Roche Business Overview

Table 50. Hoffmann-La Roche Solid Tumor Therapeutics Product

Table 51. Hoffmann-La Roche Revenue in Solid Tumor Therapeutics Business (2020-2025) & (US$ Million)

Table 52. Hoffmann-La Roche Recent Development

Table 53. Johnson & Johnson Company Details

Table 54. Johnson & Johnson Business Overview

Table 55. Johnson & Johnson Solid Tumor Therapeutics Product

Table 56. Johnson & Johnson Revenue in Solid Tumor Therapeutics Business (2020-2025) & (US$ Million)

Table 57. Johnson & Johnson Recent Development

Table 58. Novartis Company Details

Table 59. Novartis Business Overview

Table 60. Novartis Solid Tumor Therapeutics Product

Table 61. Novartis Revenue in Solid Tumor Therapeutics Business (2020-2025) & (US$ Million)

Table 62. Novartis Recent Development

Table 63. AstraZeneca Company Details

Table 64. AstraZeneca Business Overview

Table 65. AstraZeneca Solid Tumor Therapeutics Product

Table 66. AstraZeneca Revenue in Solid Tumor Therapeutics Business (2020-2025) & (US$ Million)

Table 67. AstraZeneca Recent Development

Table 68. Biogen Idec Company Details

Table 69. Biogen Idec Business Overview

Table 70. Biogen Idec Solid Tumor Therapeutics Product

Table 71. Biogen Idec Revenue in Solid Tumor Therapeutics Business (2020-2025) & (US$ Million)

Table 72. Biogen Idec Recent Development

Table 73. Boehringer Ingelheim Company Details

Table 74. Boehringer Ingelheim Business Overview

Table 75. Boehringer Ingelheim Solid Tumor Therapeutics Product

Table 76. Boehringer Ingelheim Revenue in Solid Tumor Therapeutics Business (2020-2025) & (US$ Million)

Table 77. Boehringer Ingelheim Recent Development

Table 78. GlaxoSmithKline Company Details

Table 79. GlaxoSmithKline Business Overview

Table 80. GlaxoSmithKline Solid Tumor Therapeutics Product

Table 81. GlaxoSmithKline Revenue in Solid Tumor Therapeutics Business (2020-2025) & (US$ Million)

Table 82. GlaxoSmithKline Recent Development

Table 83. Eli Lilly Company Details

Table 84. Eli Lilly Business Overview

Table 85. Eli Lilly Solid Tumor Therapeutics Product

Table 86. Eli Lilly Revenue in Solid Tumor Therapeutics Business (2020-2025) & (US$ Million)

Table 87. Eli Lilly Recent Development

Table 88. Kyowa Hakko Kirin Company Details

Table 89. Kyowa Hakko Kirin Business Overview

Table 90. Kyowa Hakko Kirin Solid Tumor Therapeutics Product

Table 91. Kyowa Hakko Kirin Revenue in Solid Tumor Therapeutics Business (2020-2025) & (US$ Million)

Table 92. Kyowa Hakko Kirin Recent Development

Table 93. Abbott Laboratories Company Details

Table 94. Abbott Laboratories Business Overview

Table 95. Abbott Laboratories Solid Tumor Therapeutics Product

Table 96. Abbott Laboratories Revenue in Solid Tumor Therapeutics Business (2020-2025) & (US$ Million)

Table 97. Abbott Laboratories Recent Development

Table 98. Baxter International Company Details

Table 99. Baxter International Business Overview

Table 100. Baxter International Solid Tumor Therapeutics Product

Table 101. Baxter International Revenue in Solid Tumor Therapeutics Business (2020-2025) & (US$ Million)

Table 102. Baxter International Recent Development

Table 103. Research Programs/Design for This Report

Table 104. Key Data Information from Secondary Sources

Table 105. Key Data Information from Primary Sources

Table 106. Authors List of This Report

List of Figures

Figure 1. Solid Tumor Therapeutics Picture

Figure 2. Global Solid Tumor Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Solid Tumor Therapeutics Market Share by Type: 2024 VS 2031

Figure 4. Chemotherapy Features

Figure 5. Hormone Therapy Features

Figure 6. Immunotherapy Features

Figure 7. Targeted Therapy Features

Figure 8. Global Solid Tumor Therapeutics Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global Solid Tumor Therapeutics Market Share by Application: 2024 VS 2031

Figure 10. Breast Cancer Case Studies

Figure 11. Lung Cancer Case Studies

Figure 12. Colorectal Cancer Case Studies

Figure 13. Prostate Cancer Case Studies

Figure 14. Cervical Cancer Case Studies

Figure 15. Others Case Studies

Figure 16. Solid Tumor Therapeutics Report Years Considered

Figure 17. Global Solid Tumor Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 18. Global Solid Tumor Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 19. Global Solid Tumor Therapeutics Market Share by Region: 2024 VS 2031

Figure 20. Global Solid Tumor Therapeutics Market Share by Players in 2024

Figure 21. Global Top Solid Tumor Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Solid Tumor Therapeutics as of 2024)

Figure 22. The Top 10 and 5 Players Market Share by Solid Tumor Therapeutics Revenue in 2024

Figure 23. North America Solid Tumor Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. North America Solid Tumor Therapeutics Market Share by Country (2020-2031)

Figure 25. United States Solid Tumor Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Canada Solid Tumor Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Europe Solid Tumor Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Europe Solid Tumor Therapeutics Market Share by Country (2020-2031)

Figure 29. Germany Solid Tumor Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. France Solid Tumor Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. U.K. Solid Tumor Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Italy Solid Tumor Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Russia Solid Tumor Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Nordic Countries Solid Tumor Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Asia-Pacific Solid Tumor Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Asia-Pacific Solid Tumor Therapeutics Market Share by Region (2020-2031)

Figure 37. China Solid Tumor Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Japan Solid Tumor Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. South Korea Solid Tumor Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Southeast Asia Solid Tumor Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. India Solid Tumor Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Australia Solid Tumor Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Latin America Solid Tumor Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Latin America Solid Tumor Therapeutics Market Share by Country (2020-2031)

Figure 45. Mexico Solid Tumor Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Brazil Solid Tumor Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Middle East & Africa Solid Tumor Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Middle East & Africa Solid Tumor Therapeutics Market Share by Country (2020-2031)

Figure 49. Turkey Solid Tumor Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Saudi Arabia Solid Tumor Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. UAE Solid Tumor Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 52. Hoffmann-La Roche Revenue Growth Rate in Solid Tumor Therapeutics Business (2020-2025)

Figure 53. Johnson & Johnson Revenue Growth Rate in Solid Tumor Therapeutics Business (2020-2025)

Figure 54. Novartis Revenue Growth Rate in Solid Tumor Therapeutics Business (2020-2025)

Figure 55. AstraZeneca Revenue Growth Rate in Solid Tumor Therapeutics Business (2020-2025)

Figure 56. Biogen Idec Revenue Growth Rate in Solid Tumor Therapeutics Business (2020-2025)

Figure 57. Boehringer Ingelheim Revenue Growth Rate in Solid Tumor Therapeutics Business (2020-2025)

Figure 58. GlaxoSmithKline Revenue Growth Rate in Solid Tumor Therapeutics Business (2020-2025)

Figure 59. Eli Lilly Revenue Growth Rate in Solid Tumor Therapeutics Business (2020-2025)

Figure 60. Kyowa Hakko Kirin Revenue Growth Rate in Solid Tumor Therapeutics Business (2020-2025)

Figure 61. Abbott Laboratories Revenue Growth Rate in Solid Tumor Therapeutics Business (2020-2025)

Figure 62. Baxter International Revenue Growth Rate in Solid Tumor Therapeutics Business (2020-2025)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Solid Tumor Cancer Treatment Market Insights Forecast to 2030

Global Brain Tumor Therapeutics Market Research Report 2024

Global Oncology Therapeutic Drug Market Research Report 2024

Global Drugs for Oncology Market Insights Forecast to 2030

Oncology Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Oncology Drugs Market Insights Forecast to 2030

Solid Tumor Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Oncology Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Targeted Therapy for Brain Cancer Market Research Report 2025

Tumor Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Brain Cancer Targeted Drug Market Research Report 2025

Global Solid Tumor Detection Market Research Report 2024

Global Rectal Cancer Therapeutics Market Insights Forecast to 2030

Global Anti tumor Drug Market Research Report 2025

Global Targeted Antitumor Drugs Market Research Report 2025

Global Solid Tumors Target Proteins Market Research Report 2024

Global Targeted Therapy for Breast Cancer Market Research Report 2025

Global Brain Tumor Diagnosis and Therapeutics Market Insights Forecast to 2030

Global Peptide Based Cancer Therapeutics Market Research Report 2024

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-5L19798

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Cancer Insurance Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-28I6901

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22R9736

Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Drugs for Differentiated Thyroid Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-29A2598

Tue Sep 09 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions